Literature DB >> 940204

Control of massive prostatic bleeding with angiographic techniques.

M E Mitchell, A C Waltman, C A Athanasoulis, W S Kerr, S P Dretler.   

Abstract

In the 4 cases reported herein angiographic techniques with selective bilateral hypogastric embolization were used to control severe prostatic hemorrhage. The technique is offered as an alternative, non-operative procedure in the management of bleeding when other modes of therapy contain significantly higher potentials for morbidity and mortality.

Entities:  

Mesh:

Year:  1976        PMID: 940204     DOI: 10.1016/s0022-5347(17)59339-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

Review 1.  Review of Current Literature for Prostatic Artery Embolization.

Authors:  Hyeon Yu; Ari J Isaacson; Charles T Burke
Journal:  Semin Intervent Radiol       Date:  2016-09       Impact factor: 1.513

2.  The value of contrast-enhanced ultrasonography in detection of prostatic infarction after prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia.

Authors:  Hippocrates Moschouris; Konstantinos Stamatiou; Katerina Malagari; Kyriaki Marmaridou; Konstantinos Kladis-Kalentzis; Michail Kiltenis; Nikolaos Papadogeorgopoulos; Aikaterini Tsavari; Kassiani Manoloudaki
Journal:  Diagn Interv Radiol       Date:  2019-03       Impact factor: 2.630

Review 3.  Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Jae Hung Jung; Karen Ann McCutcheon; Michael Borofsky; Shamar Young; Jafar Golzarian; Myung Ha Kim; Vikram M Narayan; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2022-03-29

Review 4.  The application of prostate artery embolization in the management of intractable prostate bleeding.

Authors:  Agata Stężewska; Magdalena Stężewska; Bartosz Żabicki; Maciej Salagierski
Journal:  Cent European J Urol       Date:  2020-09-15

5.  The effect of internal iliac artery embolization of the prostatic gland in the dog.

Authors:  J Darewicz; B Cylwik; A Musierowicz; S Boczon
Journal:  Int Urol Nephrol       Date:  1980       Impact factor: 2.370

Review 6.  Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.

Authors:  Juan Va Franco; Jae Hung Jung; Mari Imamura; Michael Borofsky; Muhammad Imran Omar; Camila Micaela Escobar Liquitay; Shamar Young; Jafar Golzarian; Areti Angeliki Veroniki; Luis Garegnani; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2021-07-15

7.  Clinical evaluation of embolization of the superior vesical prostatic artery for treatment of benign prostatic hyperplasia: a single-center retrospective study.

Authors:  Zhilei Qiu; Changcun Zhang; Xinsheng Wang; Kai Cheng; Xin Liang; Dawen Wang; Sichuan Hou; Xinsheng Wang
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2017-12-29       Impact factor: 1.195

8.  Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis.

Authors:  Yu-Li Jiang; Lu-Jie Qian
Journal:  BMC Urol       Date:  2019-01-28       Impact factor: 2.264

9.  Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients.

Authors:  Francisco Cesar Carnevale; Alberto Azoubel Antunes; Joaquim Mauricio da Motta Leal Filho; Luciana Mendes de Oliveira Cerri; Ronaldo Hueb Baroni; Antonio Sergio Zafred Marcelino; Geraldo Campos Freire; Airton Mota Moreira; Miguel Srougi; Giovanni Guido Cerri
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740

10.  Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Jae Hung Jung; Karen Ann McCutcheon; Michael Borofsky; Shamar Young; Jafar Golzarian; Balaji Reddy; Tae Young Shin; Myung Ha Kim; Vikram Narayan; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2020-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.